Module

Current Issues and Controversies in the Treatment of Recurrent Ovarian Cancer

Source: Managing Ovarian Cancer Recurrence: Coupling Novel Therapeutics With Optimal Treatment Decisions

Current Issues and Controversies in the Treatment of Recurrent Ovarian Cancer

Faculty:

Deborah K. Armstrong, MD

CME CREDIT INFORMATION

Release Date: 09/23/08

Expiration Date: 09/22/09

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Specify the range of current treatment options for patients with recurrent ovarian cancer
Describe results from recent clinical trials evaluating single-agent and combination regimens for the treatment of recurrent or platinum-resistant ovarian cancer
Discuss the rationale for use of novel agents with or without standard chemotherapy in the treatment of patients with recurrent ovarian cancer
Cite targeted agents under evaluation for the treatment of ovarian cancer

Topics covered include:

Introduction
Platinum-Sensitive Recurrent Ovarian Cancer
Platinum-Resistant Recurrent Ovarian Cancer
Targeted Agents in the Treatment of Ovarian Cancer
Maintenance Therapy
Predicting Treatment Response: Use of Assays and Genomics
Secondary Cytoreduction
Summary and Conclusions

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.